Source comparison
BPC-157 Dose Response Research: Study Type Comparison
Rat tendon injury models 10–500 mcg/kg daily × 14–28 days Tensile strength, collagen density, VEGF expression High internal validity, low external validity for human translation Gold standard for mechanism research; insufficient for clinical dosing guidance wi
This comparison does not assign a generated winner or score.
- Rat tendon injury models
- 10–500 mcg/kg daily × 14–28 days
- Tensile strength, collagen density, VEGF expression
- High internal validity, low external validity for human translation
- Gold standard for mechanism research; insufficient for clinical dosing guidance without human PK/PD data
- Rat gastric ulcer models
- 10 mcg/kg–10 mg/kg daily × 7–14 days
- Ulcer surface area, mucosal thickness, prostaglandin levels
- Mechanistic clarity; no human comparative data
- Demonstrates cytoprotective mechanism; doesn't validate efficacy vs standard gastroprotective drugs in humans
- In vitro cell culture studies
- 0.1–100 μg/mL medium concentration
- Cell proliferation, migration assays, gene expression
- Isolated mechanism insights; no systemic context
- Useful for pathway identification (NO/VEGF signaling); tells you nothing about bioavailability or effective human doses
- Human anecdotal reports
- 250–1000 mcg daily subcutaneous
- Subjective pain, recovery timelines
- Zero scientific validity; uncontrolled variables
- Cannot be used to infer dose-response relationships. Placebo effects, reporting bias, and confounding variables render these reports clinically meaningless